Barrington Research initiates coverage on Integra LifeSciences (Nasdaq: IART) with an Outperform rating. Price target $47.

Barrington analyst says, "We ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE